Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Deferred Taxes (2016 - 2025)

Surgery Partners' Deferred Taxes history spans 12 years, with the latest figure at $13.4 million for Q4 2025.

  • For Q4 2025, Deferred Taxes fell 88.94% year-over-year to $13.4 million; the TTM value through Dec 2025 reached $16.7 million, down 87.3%, while the annual FY2025 figure was $16.7 million, 87.3% down from the prior year.
  • Deferred Taxes for Q4 2025 was $13.4 million at Surgery Partners, up from $5.1 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $121.2 million in Q4 2024 and bottomed at -$9.7 million in Q2 2023.
  • The 5-year median for Deferred Taxes is $2.6 million (2024), against an average of $8.9 million.
  • The largest annual shift saw Deferred Taxes crashed 348.72% in 2023 before it skyrocketed 1231.87% in 2024.
  • A 5-year view of Deferred Taxes shows it stood at $11.2 million in 2021, then dropped by 15.18% to $9.5 million in 2022, then dropped by 4.21% to $9.1 million in 2023, then surged by 1231.87% to $121.2 million in 2024, then tumbled by 88.94% to $13.4 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Deferred Taxes are $13.4 million (Q4 2025), $5.1 million (Q3 2025), and -$1.5 million (Q2 2025).